Didanosine (ddI)
Pharmaceutical forms
Solid oral dosage form
Country lists
ATC N/A
Composition 100mg
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 25mg
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Buffered powder for oral liquid
Country lists
ATC N/A
Composition 100 mg packets
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Buffered powder for oral liquid
Country lists
ATC N/A
Composition 167 mg packets
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Buffered powder for oral liquid
Country lists
ATC N/A
Composition 250 mg packets
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Capsule (unbuffered enteric-coated)
Country lists
ATC N/A
Composition 125 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Capsule (unbuffered enteric-coated)
Country lists
ATC N/A
Composition 200 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Capsule (unbuffered enteric-coated)
Country lists
ATC N/A
Composition 250 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Capsule (unbuffered enteric-coated)
Country lists
ATC N/A
Composition 400 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Tablet (buffered chewable, dispersible)
Country lists
ATC N/A
Composition 25 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Colombia
2.0 AIDS
  • No observations
Tablet (buffered chewable, dispersible)
Country lists
ATC N/A
Composition 50 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Tablet (buffered chewable, dispersible)
Country lists
ATC N/A
Composition 100 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Colombia
2.0 AIDS
  • No observations
Tablet (buffered chewable, dispersible)
Country lists
ATC N/A
Composition 150 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
Tablet (buffered chewable, dispersible)
Country lists
ATC N/A
Composition 200 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
  • No observations
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • No observations
Powder for oral liquid
Country lists
ATC N/A
Composition 10mg/ml 2g
Observations for this pharmaceutical form can be found on the lists:
PAHO Strategic Fund Medicine List
2.5. Antiretrovirals
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
  • No observations
Powder for oral administration
Country lists
ATC N/A
Composition 4g
Observations for this pharmaceutical form can be found on the lists:
Chile
Essential and Prioritized Medications
  • No observations
Tablet
Country lists
ATC N/A
Composition 100 mg
Observations for this pharmaceutical form can be found on the lists:
Cuba
6.4 Antivirales
  • No observations
Tablet
Country lists
ATC N/A
Composition 100-400mg
Observations for this pharmaceutical form can be found on the lists:
Ecuador
Essential Medicines List - Ecuador
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 250mg
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Solid oral dosage form
Country lists
ATC N/A
Composition 400mg
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations
Peru
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Powder for oral administration
Country lists
ATC N/A
Composition 20mg/ml
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations